CA1325382C — Locally administrable therapeutic composition for inflammatory disease
Assigned to Senju Pharmaceutical Co Ltd · Expires 1993-12-21 · 32y expired
What this patent protects
TITLE OF THE INVENTION A locally administrable therapeutic composition for inflammatory disease ABSTRACT OF THE DISCLOSURE This invention relates to a locally administrable therapeutic composition for inflammatory disease which is characterized by comprising benzoylphenetylaceti…
USPTO Abstract
TITLE OF THE INVENTION A locally administrable therapeutic composition for inflammatory disease ABSTRACT OF THE DISCLOSURE This invention relates to a locally administrable therapeutic composition for inflammatory disease which is characterized by comprising benzoylphenetylacetic acid of the formula (wherein R is a hydrogen or halogen atom), or a salt thereof, or the hydrate of said acid or salt, as active ingredient. The ophthalmic composition according to the invention can treat effectively inflammatory eye disease by topical application, is not irritant to the eye, and has a superior effect to conventional drugs of the same or similar type. The aqueous composition prepared in accordance with this invention has an excellent stability and can be used advantageously as a nasal or otic composition as well as ophthalmic one in the treatment of inflammatory otic or nasal disease.
Drugs covered by this patent
- Lotemax (LOTEPREDNOL ETABONATE) · Bausch Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.